These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Red cell antibodies and autoimmune haemolysis after treatment with azapropazone. Chan-Lam D; Thorburn AW; Chalmers EA; Watson WH; Fitzsimons EJ Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1474. PubMed ID: 3099917 [No Abstract] [Full Text] [Related]
3. Eluate testing following microscopically positive direct antiglobulin tests with anti-IgG. Richa E; Benidt G; Tauscher C; Stowers R; Bryant S; Stubbs J Ann Clin Lab Sci; 2007; 37(2):167-9. PubMed ID: 17522373 [TBL] [Abstract][Full Text] [Related]
4. Problems in pre-transfusion tests related to drugs and chemicals. Garratty G Am J Med Technol; 1976 Jun; 42(6):209-19. PubMed ID: 779471 [TBL] [Abstract][Full Text] [Related]
5. Hypoglycaemia due to azapropazone-tolbutamide interaction. Waller DG; Waller D Br J Rheumatol; 1984 Feb; 23(1):24-5. PubMed ID: 6697069 [TBL] [Abstract][Full Text] [Related]
6. The role of macromolecular components in anti-gamma, alpha, mu, kappa, lambda, C3 and C4 antiglobulin sera. Haynes CR; Chaplin H Br J Haematol; 1971 Sep; 21(3):277-87. PubMed ID: 4998791 [No Abstract] [Full Text] [Related]
9. Skin eruptions due to azapropazone. Barker DJ; Cotterill JA Lancet; 1977 Jan; 1(8002):90. PubMed ID: 63726 [No Abstract] [Full Text] [Related]
10. A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21). Jones VE; Puttick AH; Williamson EA; Mageed RA Clin Exp Immunol; 1988 Mar; 71(3):451-8. PubMed ID: 3383449 [TBL] [Abstract][Full Text] [Related]
12. Alveolitis and haemolytic anaemia induced by azapropazone. Albazzaz MK; Harvey JE; Hoffman JN; Siddorn JA Br Med J (Clin Res Ed); 1986 Dec; 293(6561):1537-8. PubMed ID: 3099948 [No Abstract] [Full Text] [Related]
13. Interaction of azapropazone with phenytoin. Geaney DP; Carver JG; Aronson JK; Warlow CP Br Med J (Clin Res Ed); 1982 May; 284(6326):1373. PubMed ID: 6803981 [No Abstract] [Full Text] [Related]
14. Photosensitivity during treatment with azapropazone. Olsson S; Biriell C; Boman G Br Med J (Clin Res Ed); 1985 Oct; 291(6500):939. PubMed ID: 3929973 [No Abstract] [Full Text] [Related]
15. [Experience with azapropazone in rheumatology]. Gómez G; Asensi E; Obach J; Barceló P Rev Esp Reum Enferm Osteoartic; 1975; 18(3):178-89. PubMed ID: 1081251 [No Abstract] [Full Text] [Related]
16. Reversible non-oliguric impairment of renal function during azapropazone treatment. Sipilä R; Skrifvars B; Törnroth T Scand J Rheumatol; 1986; 15(1):23-6. PubMed ID: 3961430 [TBL] [Abstract][Full Text] [Related]
17. [Category, quantity and clinical significance of autoantibodies on bone marrow hematopoietic cells in patients with immunorelated cytopenia]. Fu R; Shao ZH; Liu H; He H; Jia HR; Sun J; Zhao MF; He GS; Shi J; Bai J; Chu YL; Yang TY Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):177-80. PubMed ID: 12864946 [TBL] [Abstract][Full Text] [Related]